Lilly diabetes drug Trulicity leapfrogs to No. 2 ad spender for JuneAllbiopro2018-07-19T10:42:30+09:007월 19th, 2018|
Bill Gates and others launch $30M ‘venture philanthropy’ accelerator for Alzheimer’s diagnosticsAllbiopro2018-07-19T10:42:05+09:007월 19th, 2018|
Pfizer and Lilly claim win for NGF pain drug in osteoarthritisAllbiopro2018-07-19T10:41:39+09:007월 19th, 2018|
Evoke Group’s expansion drive continues with West Coast agency buyAllbiopro2018-07-19T10:41:15+09:007월 19th, 2018|
Hydroxyapatite Chromotography Media Offers Enhanced Biomolecule PurificationAllbiopro2018-07-19T10:40:28+09:007월 19th, 2018|
Newly Public Rubius Investing $155m to Renovate Rhode Island PlantAllbiopro2018-07-19T10:40:03+09:007월 19th, 2018|
Shanghai Filling Line is Latest Investment in China for B-IAllbiopro2018-07-19T10:39:38+09:007월 19th, 2018|
Polares Medical Closes a $25M Financing to Enter Clinical ValidationAllbiopro2018-07-19T10:39:14+09:007월 19th, 2018|
Novartis, CELLforCURE Partner to Manufacture CAR-T TherapiesAllbiopro2018-07-19T10:38:49+09:007월 19th, 2018|
Winning Trump’s praise was easy for Pfizer. Wall Street and the Hill? Not so muchAllbiopro2018-07-18T09:39:25+09:007월 18th, 2018|
Vertex says it’s glad England made another offer for CF drugs, but it’ll have to do betterAllbiopro2018-07-18T09:38:31+09:007월 18th, 2018|
Statement from FDA Commissioner Scott Gottlieb, M.D. on new efforts to empower consumers by advancing access to nonprescription drugsAllbiopro2018-07-18T09:37:34+09:007월 18th, 2018|
Roivant Launches New China-Based Startup Sinovant SciencesAllbiopro2018-07-18T09:36:34+09:007월 18th, 2018|
RDD Pharma Announces IND Clearance to Advance RDD-0315 to Treat Fecal Incontinence in Patients with Spinal Cord InjuryAllbiopro2018-07-18T09:35:39+09:007월 18th, 2018|
Pfizer halts production at India injectables plant after FDA again finds issuesAllbiopro2018-07-18T09:34:38+09:007월 18th, 2018|
Ogilvy CommonHealth’s North America CEO snags new chief creative officerAllbiopro2018-07-18T09:33:40+09:007월 18th, 2018|
Nimbus veterans launch allosteric drugmaker HotSpot Therapeutics with $45M series AAllbiopro2018-07-18T09:32:43+09:007월 18th, 2018|
